106
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy

, , , ORCID Icon, , , , ORCID Icon & show all
Pages 113-120 | Received 25 Feb 2021, Accepted 19 May 2021, Published online: 01 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ezgi Aysu Şahin, Deniz Mavi, Emre Kara, Meliha Çağla Sönmezer, Ahmet Çağkan İnkaya & Serhat Ünal. (2022) Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years. Postgraduate Medicine 134:6, pages 635-640.
Read now

Articles from other publishers (2)

Vanessa Bianconi, Elena Cosentini, Massimo R. Mannarino & Matteo Pirro. 2022. Cardiovascular Complications of COVID-19. Cardiovascular Complications of COVID-19 49 71 .
Massimo R. Mannarino, Vanessa Bianconi, Bruna Gigante, Rona J. Strawbridge, Kai Savonen, Sudhir Kurl, Philippe Giral, Andries Smit, Per Eriksson, Elena Tremoli, Fabrizio Veglia, Damiano Baldassarre & Matteo Pirro. (2021) Neutrophil to lymphocyte ratio is not related to carotid atherosclerosis progression and cardiovascular events in the primary prevention of cardiovascular disease: Results from the IMPROVE study . BioFactors 48:1, pages 100-110.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.